Skip to main content
Equibles
MGTX logo

MGTX · MeiraGTx Holdings plc

Track MGTX — free

Use MGTX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$14.02 -0.17 (-1.20%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.36B
Shares
96.04M

MGTX metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.19
Market cap
$1.36B

Price action

19 metrics
Price change (1W)
-4.9%
Price change (30D)
+19.4%
Price change (3M)
+53.6%
Price change (6M)
+91.0%
Price change (YTD)
+78.5%
Price change (1Y)
+94.4%
Trailing year
Price change (5Y)
+12.4%
52-week high
$14.97
52-week low
$6.99
Change from 52-week high
-5.2%
Change from 52-week low
+103.0%
Annualized volatility
60.1%
Beta
1.7
RSI (14D)
57.7
Price vs SMA 50
+8.9%
Price vs SMA 200
+47.3%
Avg volume (3M)
839,221
Relative volume
1.1
Average dollar volume
$10.46M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
96.04M

Valuation

12 metrics
P / E (TTM)
20.0
Trailing earnings · reciprocal yield 5.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.2%
P / book
6.3
reciprocal yield 15.8%
FCF yield
0.8%
TTM · current market cap
Buyback yield
—
P / FCF
130.2
reciprocal yield 0.8%
P / operating cash flow
99.6
reciprocal yield 1.0%
Earnings yield
5.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-16

Profitability

9 metrics
Gross margin
—
Operating margin
46.3%
Trailing 12 months
Net margin
19.9%
Gross profit (TTM)
—
Operating profit (TTM)
$184.03M
Net income (TTM)
$78.98M
Trailing 12 months
Diluted EPS (TTM)
$0.71
FCF margin
2.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.43

Growth

11 metrics
Revenue growth YoY
+8,608.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$397.50M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+16.4%
Year over year · more shares
Revenue CAGR (3Y)
+72.3%
Revenue CAGR (5Y)
+39.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
36.6%
Return on assets
19.9%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
$196.13M
Free cash flow (TTM)
$10.47M
Quick ratio
—
Interest coverage
14.7
Net debt / EBITDA
-0.7
Return on invested capital
—
Trailing 12 months
Net cash
$143.17M
Latest balance sheet
Cash & equivalents
$143.17M
Total assets
$396.45M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.69M
Capital expenditures (TTM)
$3.22M
R&D (TTM)
$153.16M
SG&A (TTM)
—
Stock compensation (TTM)
$18.99M
R&D / revenue
38.5%
Stock compensation / revenue
4.8%

Ownership (13F)

3 metrics
13F filers
157
13F filer change QoQ
+24
Institutional ownership
82.5%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.97M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1735438 CUSIP G59665102 13F (30d) 134 filings 132 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)